PUBLISHER: TechNavio | PRODUCT CODE: 1788404
PUBLISHER: TechNavio | PRODUCT CODE: 1788404
The genomics market is forecasted to grow by USD 6,218.8 mn during 2024-2029, accelerating at a CAGR of 3.3% during the forecast period. The report on the genomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising investments in genomics research and development, reduction in cost of genetic sequencing, and increasing need to create and upgrade genome databases.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 3.2% |
CAGR | 3.3% |
Incremental Value | $6,218.8 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's genomics market is segmented as below:
By Solution
By Application
By Technology
By Geographical Landscape
This study identifies the advances in sequencing technologies as one of the prime reasons driving the genomics market growth during the next few years. Also, growing developments in precision medicine and gene therapy and growing demand for direct-to-consumer genetic testing will lead to sizable demand in the market.
The report on the genomics market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market vendors that include 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Cytiva, Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Co., Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Perkin Elmer Inc., Promega Corp., QIAGEN N.V., Standard BioTools Inc., and Thermo Fisher Scientific Inc.. Also, the genomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: